Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Research-and-Development" stands at 104.07 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 06/30/2024.
Shionogi & Co. Ltd.'s first quarter result of 24.89 Billion JPY for the item "Research and Development" represents a decrease of -14.66 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Shionogi & Co. Ltd.'s first quarter result of 24.89 Billion JPY for the item "Research and Development" represents a decrease of -15.44 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s first quarter result of 104.07 Billion JPY for the item "Research and Development" represents a decrease of -4.18 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.81 percent compared to the value the year prior.
The 1 year change in percent is -2.81.
The 3 year change in percent is 28.80.
The 5 year change in percent is 24.95.
The 10 year change in percent is 112.95.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Research and Development | 905,699,262,464.00 |
![]() | Johnson & Johnson - Research and Development | 486,508,953,600.00 |
![]() | AbbVie Inc - Research and Development | 399,570,305,024.00 |
![]() | Roche Holding AG - Research and Development | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Research and Development | 280,205,508,085.11 |